Beautiful paper by Delgoffe Lab! Important implications for the ex vivo generation of cell therapies! #CAR #Tcells #NKcells #immunometabolism Cell Metabolism

It was a great pleasure to talk about off-the-shelf cell therapies at the Society for Immunotherapy of Cancer winter school today! What a great session and lively discussion! Thoroughly enjoyed it! #CAR #Tcells #NK #CRISPR #celltherapy MD Anderson Cancer Center

So proud of my lab bestie Rafet! I am sure it was an amazing presentation! Hate that I missed it this time! ❤️ #NK #celltherapy #cordblood #ASTCT MD Anderson Cancer Center

Thank you Dr. Pisters - it was an honor to share the progress being made at the Institute for Cell Therapy Discovery & Innovation! Very grateful to Greater Houston Partnership for the opportunity to showcase our efforts to bring transformative cell therapies to patients. Looking forward to

Our preprint that performs virtual NK adoptive cell therapy using agent based modeling can potentially guide cell therapy development and decision support. biorxiv.org/content/10.110…

Fascinating study uncovering the mechanism by which Aspirin potentiates T cell immunity and prevents metastasis! Congratulations!! Roychoudhuri Lab nature Cambridge University #Tcells #aspririn #metastasis

Findings from a Phase I trial suggest natural killer cells pre-complexed with AFM13 has promise for specific patients with lymphoma and may be adapted for more cancer types in the future. Learn more: brnw.ch/21wRN45 #EndCancer

Please check out our paper published in Nature Medicine on our Phase I trial of AFM13-precomplexed cord blood NK cells in relapsed/refractory CD30+ lymphomas. Led by Dr. Yago Nieto and an outstanding team of coauthors and collaborators, this study marks the first clinical

This will be an amazing symposium for those interested in myeloid malignancies. Checkout the exciting program organized by simona colla ! I will be presenting some of our work on NK cell epigenetic scarring in MDS and AML. MD Anderson Cancer Center #MDS #AML #NK

Thank you for the shoutout Katy Rezvani, M.D., Ph.D ! The potential of NK cell therapy for MDS/AML is huge! MD Anderson Cancer Center #MDS #NK

Congratulations Irene! It was an amazing collaboration! 🎉🎊 thank you for all your hard work! #NK #CCUS #MDS MD Anderson Cancer Center simona colla

The MD Anderson community will dearly miss you and NYU Langone Health is lucky to have you. Enjoy this next chapter of your career Dr.Maitra! @aiims1742 MD Anderson Cancer Center

This morning at #AACR25, our Dr. Katy Rezvani shared an overview of her team’s wide-ranging CAR NK cell platform targeting hematological malignancies and solid tumors, leading to 12 ongoing clinical trials. Katy Rezvani, M.D., Ph.D AACR #EndCancer

Congratulations Courtney! MD Anderson Cancer Center #Leukemia #AACR25

Congratulations Alexander Biederstädt, MD ! Hate to have missed it. I am sure it was amazing! looking forward to your paper! #CRISPRscreen #CAR #NK MD Anderson Cancer Center Katy Rezvani, M.D., Ph.D

CISH KO TILs showing promise in a phase I clinical trial in patients with metastatic colorectal cancer! Congratulations fo Klebanoff_Lab and the team! Excited to see the potential of CISH KO immune cells in the clinic! #CISH #CRISPR #TILs

Congratulations Nicholas Huntington, Jai Rautela and team on this very elegant work! CRISPR screens will definitely advance the field of NK and CAR-NK cell therapy. Looking forward to the clinical translation of the uncovered hits! #NK #CARNK #CRISPRscreen

Congratulations Prof Paul Beavis and team on this beautiful story. Very promising approach using armoured CAR-T cells designed to enhance efficacy while decreasing toxicity, with high translational value for solid tumors. Looking forward to seeing responses in patients with solid